Skip to main content
. 2011 Jan 25;104(5):875–881. doi: 10.1038/sj.bjc.6606066

Table 3. Associations of BMI, waist circumference and WHR with prostate cancer stage.

  Reference group Stage
 
  Controls Localised OR (CI) Advanced OR (CI) P for heterogeneity
BMI
 <25.0 1178 239 1.00 27 1.00  
 25.0–29.9 2219 448 1.00 (0.84–1.19) 39 0.77 (0.47–1.27)  
 ⩾30.0 971 156 0.79 (0.63–0.98) 20 0.94 (0.52–1.69)  
 Trend P-value 0.053   0.745 0.74
             
Waist (cm)
 ⩽91.4 1781 352 1.00 36 1.00  
 91.5–99.1 1337 265 1.00 (0.84–1.19) 25 0.90 (0.54–1.51)  
 >99.1 1465 265 0.91 (0.77–1.09) 27 0.89 (0.54–1.48)  
 Trend P-value 0.355   0.585 0.82
             
WHR
 ⩽0.908 1514 291 1.00 28 1.00  
 0.909–0.952 1437 303 1.10 (0.92–1.31) 28 1.06 (0.62–1.80)  
 >0.952 1539 276 0.93 (0.78–1.11) 32 1.14 (0.68–1.90)  
 Trend P-value 0.473   0.681 0.53

Abbreviations: BMI=body mass index; CI=confidence interval; OR=odds ratio; WHR=waist-to-hip ratio.

Multinomial logistic regression model adjusted for age, survey centre, family history. All expected cell frequencies >5.

Groupings according to the WHO categorisation for BMI, and according to the distribution of controls for waist and WHR.